Deakin University
Browse

File(s) under permanent embargo

Phase II trial of alternating osimertinib with gefitinib in patients with EGFR-T790M mutation-positive advanced non-small cell lung cancer (Oscillate).

Version 2 2024-06-02, 15:11
Version 1 2023-03-17, 05:06
journal contribution
posted on 2024-06-02, 15:11 authored by Ann LivingstoneAnn Livingstone
Phase II trial of alternating osimertinib with gefitinib in patients with EGFR-T790M mutation-positive advanced non-small cell lung cancer (Oscillate).

History

Journal

Asia Pacific Journal of Clinical Oncology

Volume

14

Pagination

199-200

Location

London, Eng.

Publisher DOI

ISSN

1743-7555

Language

eng

Publication classification

E3.1 Extract of paper

Title of proceedings

Asia Pacific Journal of Clinical Oncology

Issue

S7

Publisher

Wiley

Usage metrics

    Research Publications

    Categories

    Keywords

    Uncategorised value

    Licence

    All Rights Reserved

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC